Indications:
Neoadjuvant treatment of NSCLC
OPDIVO, in combination with platinum-doublet chemotherapy, is indicated for the neoadjuvant treatment of adult patients with resectable (tumours ≥4 cm or node positive) NSCLC.
*Evaluated as part of Project Orbis
|